Cargando…

Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation

The mental health impact of the COVID-19 pandemic will increase as the outbreak continues and persist even after the pandemic passes. We developed an 11-item Coronavirus Pandemic Anxiety Scale (CPAS-11) to measure symptoms of anxiety related to the COVID-19 pandemic to help identify individuals who...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardo, Allan B. I., Mendoza, Norman B., Simon, Patricia D., Cunanan, Angela Lorraine P., Dizon, John Ian Wilzon T., Tarroja, Maria Caridad H., Ma. Balajadia-Alcala, Araceli, Saplala, Jesus Enrique G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664585/
https://www.ncbi.nlm.nih.gov/pubmed/33223781
http://dx.doi.org/10.1007/s12144-020-01193-2
_version_ 1783609863437287424
author Bernardo, Allan B. I.
Mendoza, Norman B.
Simon, Patricia D.
Cunanan, Angela Lorraine P.
Dizon, John Ian Wilzon T.
Tarroja, Maria Caridad H.
Ma. Balajadia-Alcala, Araceli
Saplala, Jesus Enrique G.
author_facet Bernardo, Allan B. I.
Mendoza, Norman B.
Simon, Patricia D.
Cunanan, Angela Lorraine P.
Dizon, John Ian Wilzon T.
Tarroja, Maria Caridad H.
Ma. Balajadia-Alcala, Araceli
Saplala, Jesus Enrique G.
author_sort Bernardo, Allan B. I.
collection PubMed
description The mental health impact of the COVID-19 pandemic will increase as the outbreak continues and persist even after the pandemic passes. We developed an 11-item Coronavirus Pandemic Anxiety Scale (CPAS-11) to measure symptoms of anxiety related to the COVID-19 pandemic to help identify individuals who might need mental health services. In developing the scale items, we considered previous research and theory on anxiety symptoms and symptoms reported by clinically referred cases in the Philippines. The scale was validated in a Filipino sample (N = 925). Exploratory factor analysis indicated two factors corresponding to somatic and non-somatic symptoms; confirmatory factor analysis showed good fit for the two-factor model. CPAS-11 showed good internal consistency, convergent and divergent validity, and screening accuracy. A cutoff score of 15 showed adequate sensitivity and specificity to distinguish GAD-7 screened participants. The results support the viability of CPAS-11 as a screening tool to identify individuals experiencing COVID-19-related anxiety.
format Online
Article
Text
id pubmed-7664585
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-76645852020-11-16 Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation Bernardo, Allan B. I. Mendoza, Norman B. Simon, Patricia D. Cunanan, Angela Lorraine P. Dizon, John Ian Wilzon T. Tarroja, Maria Caridad H. Ma. Balajadia-Alcala, Araceli Saplala, Jesus Enrique G. Curr Psychol Article The mental health impact of the COVID-19 pandemic will increase as the outbreak continues and persist even after the pandemic passes. We developed an 11-item Coronavirus Pandemic Anxiety Scale (CPAS-11) to measure symptoms of anxiety related to the COVID-19 pandemic to help identify individuals who might need mental health services. In developing the scale items, we considered previous research and theory on anxiety symptoms and symptoms reported by clinically referred cases in the Philippines. The scale was validated in a Filipino sample (N = 925). Exploratory factor analysis indicated two factors corresponding to somatic and non-somatic symptoms; confirmatory factor analysis showed good fit for the two-factor model. CPAS-11 showed good internal consistency, convergent and divergent validity, and screening accuracy. A cutoff score of 15 showed adequate sensitivity and specificity to distinguish GAD-7 screened participants. The results support the viability of CPAS-11 as a screening tool to identify individuals experiencing COVID-19-related anxiety. Springer US 2020-11-13 2022 /pmc/articles/PMC7664585/ /pubmed/33223781 http://dx.doi.org/10.1007/s12144-020-01193-2 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Bernardo, Allan B. I.
Mendoza, Norman B.
Simon, Patricia D.
Cunanan, Angela Lorraine P.
Dizon, John Ian Wilzon T.
Tarroja, Maria Caridad H.
Ma. Balajadia-Alcala, Araceli
Saplala, Jesus Enrique G.
Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation
title Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation
title_full Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation
title_fullStr Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation
title_full_unstemmed Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation
title_short Coronavirus Pandemic Anxiety Scale (CPAS-11): development and initial validation
title_sort coronavirus pandemic anxiety scale (cpas-11): development and initial validation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664585/
https://www.ncbi.nlm.nih.gov/pubmed/33223781
http://dx.doi.org/10.1007/s12144-020-01193-2
work_keys_str_mv AT bernardoallanbi coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation
AT mendozanormanb coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation
AT simonpatriciad coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation
AT cunananangelalorrainep coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation
AT dizonjohnianwilzont coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation
AT tarrojamariacaridadh coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation
AT mabalajadiaalcalaaraceli coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation
AT saplalajesusenriqueg coronaviruspandemicanxietyscalecpas11developmentandinitialvalidation